Effect of GERD on clinical severity and functional characteristics of lung function in asthma Source: Annual Congress 2011 - Clinical parameters in airway diseases Year: 2011
The relationship between radiological severity and clinical phenotype in bronchiectasis Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019
BREATHE – Distribution and co-expression of T2 biomarkers in asthma and association with severity, clinical characteristics and co-morbidities Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
Influence of statin therapy on clinical symptoms, severity and prognosis in patients with community acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008
Using characteristics of asthma phenotypes to determine exacerbation severity Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020
Correlation between indices of quality of life and degree of severity of symptoms in patients with asthma in combination with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 520s Year: 2004
Baseline characteristics of severe asthma patients initiating biologic treatment worldwide Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
Effects of exacerbation risk on symptoms and clinical characteristics in patients with bronchiectasis Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012
Comparison of severity of clinical, functional signs of COPD with the frequency and severity of mental disorders Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017
The relationship of comorbidities with clinical and phsyiological parameters in COPD Source: Annual Congress 2012 - COPD comorbidities II Year: 2012
Clinical and functional effectiveness of atorvastatin in complex therapy of severe bronchial asthma Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009
The cost-efficacy of combined anti-inflammatory therapy in the treatment of children in severe persistent asthma Source: Eur Respir J 2003; 22: Suppl. 45, 134s Year: 2003
Associations of COPD severity and severity of exacerbation with sputum microbiologic profile and long-term survival Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008
The characteristics of treatment failure with omalizumab in patients with severe asthma: The impact of eosinophilic complication Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Effect of comorbidities on severity and clinical parameters of COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001
Differences in clinical and inflammatory characteristics between steroid-withdrawal-induced and spontaneous exacerbations in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 199s Year: 2002
The correlation between smoking and histopathological, radiological and clinical characteristics of lung cancer in Turkish female patients Source: Eur Respir J 2005; 26: Suppl. 49, 156s Year: 2005
The correlation of BAL cells and clinical-functional parameters in children with stable asthma after antileukotriene therapy Source: Eur Respir J 2003; 22: Suppl. 45, 101s Year: 2003